MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$690,000
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Other revenue
0
-
-702,000*
0
Research and development
247,000
200,000
483,500*
177,000
General and administrative
460,000
514,000
1,312,250*
547,000
Gain on sale of baergic
-
-
50,750*
-
Total operating expenses
707,000
-
1,745,000*
724,000
Income (loss) from operations
-707,000
-714,000
-2,447,000*
-724,000
Interest income
17,000
18,000
23,500*
34,000
Loss on common stock warrant liabilities
-
-
0*
0
Change in fair value of warrant liabilities
0
-1,000
-16,500*
2,000
Total other income
17,000
19,000
-
32,000
Net income (loss)
-690,000
-695,000
-2,407,000*
-692,000
Net loss attributable to non-controlling interests
0
0
-20,000*
-
Net income (loss) attributable to avenue
-690,000
-695,000
-2,387,000
-683,000
Net income (loss) attributable to common stockholders
-690,000
-
-
-
Basic EPS
-0.21
-0.21
-0.789
-0.21
Basic Average Shares
3,294,967
3,293,729
3,026,277
3,183,558
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net income (loss)
attributable to common...
-$690,000
Net income (loss)
attributable to avenue
-$690,000
(-305.97%↓ Y/Y)
Interest income
$17,000
(-45.16%↓ Y/Y)
Net income (loss)
-$690,000
(-309.73%↓ Y/Y)
Total other income
$17,000
(-46.88%↓ Y/Y)
Income (loss) from
operations
-$707,000
(-338.05%↓ Y/Y)
Total operating
expenses
$707,000
(-36.13%↓ Y/Y)
General and
administrative
$460,000
(-49.73%↓ Y/Y)
Research and development
$247,000
(28.65%↑ Y/Y)
Buy us a coffee
AVENUE THERAPEUTICS, INC. (ATXI)
AVENUE THERAPEUTICS, INC. (ATXI)